Key Takeaways
- Shares of AXT plummeted approximately 16% following a remarkable 548% year-to-date surge
- Chief Executive Morris Young sold more than $22 million worth of shares, triggering investor concern
- Board member Jesse Chen disposed of over $664,000 in holdings on June 4
- Current trading levels significantly exceed Wall Street’s consensus price target of $43.80, with shares previously trading between $89–$108
- The company’s postponed annual shareholder meeting was held on June 4
Shares of AXT Inc (AXTI) experienced a significant decline on June 5, tumbling approximately $16.95 to settle around $89.04. This represents a substantial single-day retreat of roughly 16%.
The selloff follows a spectacular rally that saw AXT shares soar 548% since the beginning of the year, driving the stock far beyond levels that Wall Street analysts consider justifiable.
The catalyst for Thursday’s decline appears to be significant insider transactions. CEO Morris Young divested more than $22 million in company stock, a transaction that unsettled investors who had been benefiting from the stock’s meteoric rise.
Board member Jesse Chen also participated in the selling, disposing of 6,133 shares on June 4 at an average execution price of $108.28, generating approximately $664,081 in proceeds. This transaction trimmed his holdings by more than 6%, leaving him with 94,193 shares valued at roughly $10.2 million.
Chen’s recent sale is part of a broader pattern of divestiture. In preceding months, he has sold tens of thousands of shares at prices spanning from approximately $37 to $111 per share.
Significant Price-Target Disconnect
The semiconductor company’s primary challenge may be the substantial gap between its market price and analyst valuations. Wall Street’s consensus price target stands at merely $43.80, representing a fraction of the stock’s pre-decline trading levels.
Northland Securities maintains the highest price objective at $125.00, while B. Riley occupies the opposite end of the spectrum with a $21.00 target accompanied by a “neutral” stance. Wedbush recently increased its target to $28.00 with an “outperform” rating, though this remains substantially below recent market prices.
The analyst community remains divided with two Buy recommendations, two Hold ratings, and one Sell rating. This lack of consensus has done little to stabilize the stock following the substantial insider transactions.
Financial Performance and Forward Outlook
AXT unveiled its latest quarterly financial results on April 30. The substrate manufacturer reported a per-share loss of $0.01, surpassing the consensus forecast of a $0.04 deficit. Quarterly revenue reached $26.92 million, modestly exceeding analyst projections of $26.22 million.
For the upcoming second quarter of 2026, management provided guidance calling for earnings between $0.06 and $0.08 per share — indicating the company anticipates returning to profitability in the near term.
For the complete fiscal year, Wall Street currently projects AXT will generate $0.20 in earnings per share.
The company conducted its annual shareholder meeting on June 4 following an earlier postponement caused by insufficient attendance. This rescheduled event contributed to the news flow surrounding the stock during an already volatile period.
Institutional stakeholders currently control approximately 49.52% of outstanding shares. Notable recent activity includes Ariose Capital Management establishing a new position valued at roughly $39 million during the first quarter, while Assenagon Asset Management expanded its holdings by 161.9% to exceed 1.5 million shares.
AXTI’s 52-week trading range extends from a low of $1.72 to a peak of $143.16, with Thursday’s closing price of $89.04 positioned between these boundaries.
The stock’s 50-day moving average currently stands at $88.78, while the 200-day moving average sits at $46.83.





